Hälsa och vård innan konception

Tidsperiod: 2015-07-01 till 2015-07-31

Projektledare: Tanja Tydén

Finansiär: Vetenskapsrådet

Bidragstyp: Internationellt samarbete

Budget: 100 000 SEK

Preconception Health and Care International Conference, Uppsala 2016-02-17, 18 and 19Preconception care is defined as a set of interventions that aim to identify and modify biomedical behavioural and social risk to a woman´s health or pregnancy outcome through prevention and management. As an example women are advised to take 400 μg folic acid daily, at least one month before conception and up to 12 weeks after conception to decrease the risk of neural tube defects in the fetus. As the majority of women attend antenatal clinics in gestational weeks 8-12 it is too late to inform them about the importance of this supplementation as well as to advice them about other risks such as poorly controlled chronic conditions, overweight and use of teratogen medications. Globally, at least four out of ten women report that their pregnancies are unplanned, which highlights the need for population wide approaches for evidence based preconception care. As a result of the first European Congress in Preconception Health and Care, held in Brussels in 2010, we were a group of researchers from Denmark, Sweden, UK, Netherlands, Belgium and Italy and Ukraine a network called PrePreg was started. This network is lead by researchers at Uppsala University. Recently we published a joint paper on preconception care across six European countries. Our results showed that all countries had preconception recommendations for women with chronic diseases, but recommendations for addressing other key preventative health issues for women and men were fragmented and inconsistent. We concluded that collaborative research across Europe is required in order to develop evidence-based guidelines for preconception health and care and that there is a need to establish a clear strategy for promoting evidence based advice and guidance within the European childbearing population.Investment in preconception care has the potential to prevent unintended pregnancies, complications during pregnancy and delivery, stillbirths, preterm birth and low birth weight, birth defects, neonatal infections, and vertical transmission of HIV/STIs. It can also lower the risk of some forms of childhood cancer, decrease the risk of type 2 diabetes and cardiovascular disease later in life and reduce maternal and child mortalityImplementing evidence-based preconception care programs is important for women both in high- and low-income countries. In high-income countries many women postpone childbearing until ages when their fecundity has decreased, whereas many women in low-income countries would benefit from delaying their first pregnancy and space subsequent pregnancies (WHO 2013). As a part of the needed investment in improving preconception health, we would like to convene an international conference to share best practices and the most recent evidence in the field as well as to promote international on preconception health and care. The congress objectives are to: (1) review the status of preconception health and care are in Europe and globally, (2) present recent preconception health research results, (3) exchange experiences with different methodology used in clinical research including issues relating to gender and ethics, (4) exchange experiences of implementing and evaluating reproductive health care interventions, including the use of social media to promote preconception behaviour change, (5) to develop new research collaboration.For additional information please visit: www.pubcare.uu.se